Cipla informs about company updates

16 Mar 2016 Evaluate

With reference to the earlier intimation dated May 12, 2014, Cipla has now informed that Cipla (EU), UK (‘Cipla UK’), a wholly owned subsidiary of the Company, has pursuant to the approval of the board of Cipla UK, made an additional investment of USD 3 million in Chase Pharmaceuticals Corporation Inc., US (‘Chase’) towards full settlement of its obligation under the agreed arrangement for investment in Chase. Consequently, Cipla UK’s total investment in Chase would aggregate to approximately USD 5.12 million for a 16.7% stake on a fully diluted basis.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1377.85 -13.35 (-0.96%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×